Izindaba zenkampani

Izindaba Ezijabulisayo | I-JYMed's Liraglutide API Ithola Isitifiketi Se-WC
ngo-admin ku-24-10-17
Ngomhla ziyi-12 kuMfumfu, 2024, i-JYMed's Liraglutide API yathola isitifiketi Sokuqinisekisa Okubhaliwe (WC), okumaka isinyathelo esibalulekile sokuthunyelwa ngempumelelo kwe-API emakethe ye-EU. I-WC (Isiqiniseko Esibhaliwe)...
Funda kabanzi
Sihalalisela I-Tirzepatide ye-JYMed Iqeda Ukugcwalisa kwe-US-DMF
ngo-admin ku-24-08-12
I-JYMed Technology Co., Ltd. iyajabula ukumemezela ukuthi umkhiqizo wayo, i-Tirzepatide, iqede ngempumelelo ukubhaliswa kwe-Drug Master File (DMF) ne-US FDA (Inombolo ye-DMF: 040115) futhi yathola I-Acknowl ye-FDA...
Funda kabanzi
I-JYMed Peptide ikumema ukuthi uhambele uMbukiso Wezithako Zezimonyo wase-Korea wango-2024
ngo-admin ku-24-07-16
Indawo: I-Korea International Exhibition Centre Usuku: Julayi 24-26, 2024 Isikhathi: 10:00 AM - 5:00 PM Ikheli: I-COEX Exhibition Center Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-cosmetics iyinhlangano iqembu lemibukiso yamazwe ngamazwe elihamba phambili ekunakekelweni komuntu siqu...
Funda kabanzi